Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Caprioli

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2019
Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)Vincenzo Villanacci, Luca Reggiani-Bonetti, Flavio Caprioli, et al.
Journal of Crohn'S & Colitis|June 11, 2016
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel DiseasesJoana Torres, Flavio Caprioli, Konstantinos H Katsanos, et al.
European Journal of Immunology|January 18, 2008
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosaRoberta Caruso, Daniele Fina, Omero Alessandro Paoluzi, et al.
Nutrients|October 16, 2024
The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn's Disease in Italy: An IG-IBD SurveyTommaso Pessarelli, Matilde Topa, Andrea Sorge, et al.
Inflammatory Bowel Diseases|March 2, 2013
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapyFlavio Caprioli, Francesca Bosè, Riccardo L Rossi, et al.
Journal of Crohn'S & Colitis|February 27, 2020
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel DiseasesMarina Coletta, Moira Paroni, Maria Francesca Alvisi, et al.
Journal of Crohn'S & Colitis|December 1, 2021
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel DiseasesMarina Coletta, Moira Paroni, Maria Francesca Alvisi, et al.
Oncotarget|February 10, 2018
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissueEleonora Franzè, Vicenzo Dinallo, Angela Rizzo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2018
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective studyAnna Viola, Daniela Pugliese, Sara Renna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 1, 2024
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter studyOlga Maria Nardone, Dario Bruzzese, Mariangela Allocca, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2019
Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)Vincenzo Villanacci, Luca Reggiani-Bonetti, Flavio Caprioli, et al.
Journal of Crohn'S & Colitis|June 11, 2016
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel DiseasesJoana Torres, Flavio Caprioli, Konstantinos H Katsanos, et al.
European Journal of Immunology|January 18, 2008
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosaRoberta Caruso, Daniele Fina, Omero Alessandro Paoluzi, et al.
Nutrients|October 16, 2024
The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn's Disease in Italy: An IG-IBD SurveyTommaso Pessarelli, Matilde Topa, Andrea Sorge, et al.
Inflammatory Bowel Diseases|March 2, 2013
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapyFlavio Caprioli, Francesca Bosè, Riccardo L Rossi, et al.
Journal of Crohn'S & Colitis|February 27, 2020
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel DiseasesMarina Coletta, Moira Paroni, Maria Francesca Alvisi, et al.
Journal of Crohn'S & Colitis|December 1, 2021
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel DiseasesMarina Coletta, Moira Paroni, Maria Francesca Alvisi, et al.
Oncotarget|February 10, 2018
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissueEleonora Franzè, Vicenzo Dinallo, Angela Rizzo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2018
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective studyAnna Viola, Daniela Pugliese, Sara Renna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 1, 2024
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter studyOlga Maria Nardone, Dario Bruzzese, Mariangela Allocca, et al.
Pageof 18